Description
The increased activity in ophthalmic research is reflected in the long list of world-wide clinical studies in their various stages: nearly 300 studies of various aspects of glaucoma and close to 250 studies on ocular surface, cornea and dry eye. Searching the web for retina clinical studies yields about 250 studies, about 190 studies are listed for macular edema and approximately 70 studies for AMD. This clinical bustle heralds the changes that we will soon see in the practice of ophthalmology.
ISOPT 2010 based on its new theme in 2009 will bring to focus the latest novelties in medical devices including innovations in ocular drug delivery such as slow release devices implanted in the eye and new imaging technology that better allow to evaluate the effect of drugs and other therapeutic modalities.
ISOPT Asia will follow the footsteps of ISOPT 8th in Rome allowing participants to have a glimpse to the near future with critical look at the current best practices available to our patients today. The ISOPT program is geared to provide a continuum, spreading from basic development of therapeutic concepts to their utilization as drugs and technologies in clinical reality. Considerations common to drug development will be discussed with the main players in the field i.e. researchers based in the academia, clinical investigators, regulatory affairs and the industry professionals. Topics on drug development process of mutual interest such as the evolution of endpoints and ethical considerations will be raised in round table discussions.
Asia is becoming a center of excellence in clinical research and innovative ideas. The interplay of innovative ideas on one side and traditional medicine on the other may offer new venues of development and progress. ISOPT is therefore seeking to become a foundation of combined east and west wealth of ocular therapeutic knowledge.
